Idiopathic Pulmonary Fibrosis Cohort of TCM
ConditionIdiopathic Pulmonary Fibrosis (IPF)
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorHenan University of Traditional Chinese Medicine
About this trial
This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.
Eligibility criteria
Qualifiers
Patients diagnosed with IPF;
Age ≥ 40 years old;
Voluntary participation in this study,And sign the informed consent form.
Disqualifiers
Patients with confusion, dementia, consciousness disorders, and various mental illnesses;
Patients who are unable to take care of themselves and have been bedridden for a long time.
Trial design
Treatments tested in this trial
- Traditional Chinese medicine (TCM)
- Non-traditional Chinese medicine (non-TCM)
Treatment groups
1,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Henan University of Traditional Chinese Medicine
Lead sponsor
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator
China-Japan Friendship Hospital
Collaborator
The First Affiliated Hospital of Zhengzhou University
Collaborator
Shanghai Pulmonary Hospital, Shanghai, China
Collaborator
Source ClinicalTrials.gov